1. Home
  2. INAB vs MMA Comparison

INAB vs MMA Comparison

Compare INAB & MMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • MMA
  • Stock Information
  • Founded
  • INAB 2016
  • MMA 2013
  • Country
  • INAB United States
  • MMA Australia
  • Employees
  • INAB N/A
  • MMA N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • MMA
  • Sector
  • INAB Health Care
  • MMA
  • Exchange
  • INAB Nasdaq
  • MMA Nasdaq
  • Market Cap
  • INAB 10.6M
  • MMA 20.2M
  • IPO Year
  • INAB 2021
  • MMA 2024
  • Fundamental
  • Price
  • INAB $2.10
  • MMA $1.43
  • Analyst Decision
  • INAB Strong Buy
  • MMA
  • Analyst Count
  • INAB 2
  • MMA 0
  • Target Price
  • INAB $108.00
  • MMA N/A
  • AVG Volume (30 Days)
  • INAB 63.9K
  • MMA 492.6K
  • Earning Date
  • INAB 11-10-2025
  • MMA 01-01-0001
  • Dividend Yield
  • INAB N/A
  • MMA N/A
  • EPS Growth
  • INAB N/A
  • MMA N/A
  • EPS
  • INAB N/A
  • MMA N/A
  • Revenue
  • INAB N/A
  • MMA $407,412.00
  • Revenue This Year
  • INAB N/A
  • MMA N/A
  • Revenue Next Year
  • INAB N/A
  • MMA N/A
  • P/E Ratio
  • INAB N/A
  • MMA N/A
  • Revenue Growth
  • INAB N/A
  • MMA N/A
  • 52 Week Low
  • INAB $1.91
  • MMA $0.60
  • 52 Week High
  • INAB $12.53
  • MMA $4.11
  • Technical
  • Relative Strength Index (RSI)
  • INAB 44.97
  • MMA 46.80
  • Support Level
  • INAB $2.04
  • MMA $1.39
  • Resistance Level
  • INAB $2.15
  • MMA $1.59
  • Average True Range (ATR)
  • INAB 0.10
  • MMA 0.10
  • MACD
  • INAB -0.01
  • MMA -0.02
  • Stochastic Oscillator
  • INAB 18.16
  • MMA 12.90

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About MMA Alta Global Group Limited

Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.

Share on Social Networks: